Research programme: anti-infectives - Clinical Data/VDDI

Drug Profile

Research programme: anti-infectives - Clinical Data/VDDI

Latest Information Update: 03 Apr 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Alabama
  • Developer Clinical Data
  • Class
  • Mechanism of Action Nicotinamide adenine dinucleotide antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Anthrax

Most Recent Events

  • 20 Dec 2005 Icoria has been acquired and merged into Clinical Data
  • 24 Aug 2004 Paradigm Genetics is now called Icoria
  • 02 Apr 2002 Preclinical trials in Anthrax in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top